<- Go Home
Khiron Life Sciences Corp.
Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products. The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health professionals. It sells its products in Colombia, Peru, Germany, the United Kingdom, Brazil, Uruguay, and Mexico. The company is headquartered in Bogota, Colombia.
Market Cap
$330.00
Volume
207.0K
Cash and Equivalents
$1.9M
EBITDA
-$16.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$6.7M
Profit Margin
41.34%
52 Week High
$0.00
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.00
Price / Earnings
-0.00
Price / Tangible Book Value
0.00
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$17.4M
Return on Equity
74.68%
Return on Assets
-20.79
Cash and Short Term Investments
$1.9M
Debt
$2.6M
Equity
$27.1M
Revenue
$16.1M
Unlevered FCF
-$8.6M
Sector
Pharmaceuticals
Category
N/A